Holen Sie sich die Stockscreener-App
2.19
0.00%
0.00
Schlusskurs vom Vortag:
$2.19
Offen:
$2.16
24-Stunden-Volumen:
472.35K
Relative Volume:
1.50
Marktkapitalisierung:
$230.42M
Einnahmen:
$7.05M
Nettoeinkommen (Verlust:
$-30.43M
KGV:
-5.7814
EPS:
-0.3788
Netto-Cashflow:
$21.84M
1W Leistung:
-10.61%
1M Leistung:
+14.66%
6M Leistung:
+18.38%
1J Leistung:
+18.38%
1-Tages-Spanne:
$2.04
$2.215
1-Wochen-Bereich:
$2.04
$2.48
52-Wochen-Spanne:
$1.07
$4.62
Proqr Therapeutics N V Stock (PRQR) Company Profile
Firmenname
Proqr Therapeutics N V
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PRQR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRQR
Proqr Therapeutics N V
|
2.19 | 237.02M | 7.05M | -30.43M | 21.84M | -0.3788 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Proqr Therapeutics N V Stock (PRQR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-04-29 | Eingeleitet | Evercore ISI | Outperform |
| 2025-03-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-01-10 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-29 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-11-08 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2023-03-30 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-12-22 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2022-02-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2022-02-11 | Herabstufung | Stifel | Buy → Hold |
| 2022-02-01 | Eingeleitet | Raymond James | Strong Buy |
| 2021-05-03 | Eingeleitet | Stifel | Buy |
| 2021-03-25 | Bestätigt | Citigroup | Buy |
| 2020-11-03 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-03-12 | Bestätigt | Chardan Capital Markets | Buy |
| 2018-12-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2018-11-15 | Eingeleitet | Citigroup | Buy |
| 2018-09-19 | Eingeleitet | Evercore ISI | Outperform |
| 2017-09-26 | Bestätigt | JMP Securities | Mkt Outperform |
| 2016-06-20 | Eingeleitet | Chardan Capital Markets | Neutral |
| 2014-10-15 | Eingeleitet | Deutsche Bank | Buy |
| 2014-10-13 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Proqr Therapeutics N V Aktie (PRQR) Neueste Nachrichten
Published on: 2025-09-13 04:31:13 - Newser
Is it time to cut losses on ProQR Therapeutics N.V.July 2025 Drop Watch & Safe Entry Point Identification - Newser
Should you wait for a breakout in ProQR Therapeutics N.V.2025 Top Gainers & Fast Entry Momentum Alerts - Newser
Forecasting ProQR Therapeutics N.V. price range with options data2025 Market WrapUp & Accurate Trade Setup Notifications - Newser
Can technical indicators confirm ProQR Therapeutics N.V.’s reversalPortfolio Update Report & Verified Momentum Stock Alerts - Newser
Can trapped investors hope for a rebound in ProQR Therapeutics N.V.2025 Big Picture & Advanced Swing Trade Entry Plans - Newser
Visual trend scoring systems applied to ProQR Therapeutics N.V.July 2025 PostEarnings & Weekly Chart Analysis and Guides - Newser
Evaluating ProQR Therapeutics N.V. with trendline analysis2025 Institutional Moves & Risk Controlled Swing Trade Alerts - Newser
ProQR Therapeutics N.V. stock trend outlook and recovery pathJuly 2025 Short Interest & Weekly High Conviction Trade Ideas - Newser
Adage Capital Partners GP L.L.C. Sells 1,500,182 Shares of ProQR Therapeutics N.V. $PRQR - MarketBeat
When is the best time to exit ProQR Therapeutics N.V.July 2025 Review & Technical Analysis for Trade Confirmation - Newser
Using RSI to spot recovery in ProQR Therapeutics N.V.2025 Macro Impact & Free Daily Entry Point Trade Alerts - Newser
Will earnings trigger a reversal in ProQR Therapeutics N.V.Weekly Gains Report & AI Powered Market Trend Analysis - Newser
Measuring ProQR Therapeutics N.V.’s beta against major indicesEarnings Overview Summary & Safe Entry Trade Signal Reports - Newser
What earnings revisions data tells us about ProQR Therapeutics N.V.Market Performance Recap & Weekly Stock Performance Updates - Newser
What technical models suggest about ProQR Therapeutics N.V.’s comebackWeekly Profit Analysis & Breakout Confirmation Alerts - Newser
What institutional flow reveals about ProQR Therapeutics N.V.2025 Momentum Check & Weekly Chart Analysis and Guides - Newser
What Fibonacci levels say about ProQR Therapeutics N.V. reboundQuarterly Earnings Summary & Verified Momentum Stock Ideas - Newser
Is ProQR Therapeutics N.V. stock entering bullish territoryJuly 2025 Sector Moves & Fast Entry and Exit Trade Plans - Newser
How to recover losses in ProQR Therapeutics N.V. stockForecast Cut & Weekly Setup with ROI Potential - Newser
Heatmap analysis for ProQR Therapeutics N.V. and competitorsJuly 2025 Trends & Momentum Based Trading Ideas - Newser
Chart based analysis of ProQR Therapeutics N.V. trendsMarket Trend Report & Safe Capital Growth Tips - Newser
Ranking ProQR Therapeutics N.V. among high performing stocks via toolsJuly 2025 News Drivers & Proven Capital Preservation Tips - Newser
Can ProQR Therapeutics N.V. hit a new high this monthJuly 2025 Highlights & Consistent Growth Equity Picks - Newser
Is ProQR Therapeutics N.V. meeting your algorithmic filter criteriaJuly 2025 Fed Impact & Expert Approved Momentum Trade Ideas - Newser
What high frequency data says about ProQR Therapeutics N.V.2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser
Is ProQR Therapeutics N.V. building a consolidation baseJuly 2025 WrapUp & Free Long-Term Investment Growth Plans - Newser
statistical indicators supporting proqr therapeutics n.v.’s strengthJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - Newser
Momentum divergence signals in ProQR Therapeutics N.V. chartEarnings Risk Summary & Technical Buy Zone Confirmation - Newser
Analysis Recap: Is ProQR Therapeutics N.V. stock a good dividend stock2025 Investor Takeaways & Precise Trade Entry Recommendations - Lancaster City Council
Will ProQR Therapeutics N.V. price bounce be sustainableMarket Volume Summary & Weekly Momentum Stock Picks - Newser
Will ProQR Therapeutics N.V. see short term momentumEarnings Performance Report & Free Real-Time Market Sentiment Alerts - Newser
American Century Companies Inc. Decreases Stock Position in ProQR Therapeutics N.V. $PRQR - Defense World
ProQR Therapeutics N.V. Forms Bullish Flag — Upside AheadJobs Report & Daily Volume Surge Trade Alerts - beatles.ru
Finanzdaten der Proqr Therapeutics N V-Aktie (PRQR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):